No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d4iuaA1, 1.0000, 0.00, 1.000, 91, 91, CRYSTAL STRUCTURE OF THE NK2 FRAGMENT (31-290) OF THE MOUSE HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR
2, d4iuaD1, 0.9813, 0.49, 1.000, 91, 91, CRYSTAL STRUCTURE OF THE NK2 FRAGMENT (31-290) OF THE MOUSE HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR
3, d4iuaE1, 0.9681, 0.66, 1.000, 91, 91, CRYSTAL STRUCTURE OF THE NK2 FRAGMENT (31-290) OF THE MOUSE HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR
4, d4iuaB1, 0.9671, 0.73, 1.000, 91, 91, CRYSTAL STRUCTURE OF THE NK2 FRAGMENT (31-290) OF THE MOUSE HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR
5, d4iuaC1, 0.9615, 0.74, 1.000, 91, 91, CRYSTAL STRUCTURE OF THE NK2 FRAGMENT (31-290) OF THE MOUSE HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR
6, d4iuaF1, 0.9576, 0.77, 1.000, 91, 91, CRYSTAL STRUCTURE OF THE NK2 FRAGMENT (31-290) OF THE MOUSE HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR
7, d3hmrA_, 0.9389, 1.05, 1.000, 90, 90, CRYSTAL STRUCTURE OF THE N-TERMINAL FRAGMENT (31-127) OF THE MOUSE HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR
8, d2qj2B1, 0.9265, 1.30, 0.835, 92, 91, A MECHANISTIC BASIS FOR CONVERTING A RECEPTOR TYROSINE KINASE AGONIST TO AN ANTAGONIST
9, d2qj4B1, 0.9259, 1.05, 1.000, 89, 89, A MECHANISTIC BASIS FOR CONVERTING A RECEPTOR TYROSINE KINASE AGONIST TO AN ANTAGONIST
10, d2qj4A1, 0.9259, 1.05, 1.000, 89, 89, A MECHANISTIC BASIS FOR CONVERTING A RECEPTOR TYROSINE KINASE AGONIST TO AN ANTAGONIST
11, d3hmsA_, 0.9192, 1.52, 0.835, 91, 91, CRYSTAL CRYSTAL STRUCTURE OF THE N-TERMINAL FRAGMENT (28-126) OF THE HUMAN HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR ORTHORHOMBIC CRYSTAL FORM
12, d3hmtA_, 0.9160, 1.31, 0.835, 91, 91, CRYSTAL STRUCTURE OF THE N-TERMINAL FRAGMENT (28-126) OF THE HUMAN HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR TRIGONAL CRYSTAL FORM
13, d3hmtB_, 0.9156, 1.30, 0.835, 91, 91, CRYSTAL STRUCTURE OF THE N-TERMINAL FRAGMENT (28-126) OF THE HUMAN HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR TRIGONAL CRYSTAL FORM
14, d1bhtB1, 0.9126, 1.49, 0.835, 91, 91, NK1 FRAGMENT OF HUMAN HEPATOCYTE GROWTH FACTOR
15, d3mkpA1, 0.9122, 1.37, 0.835, 91, 91, CRYSTAL STRUCTURE OF 1K1 MUTANT OF HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR FRAGMENT NK1 IN COMPLEX WITH HEPARIN
16, d3mkpB1, 0.9116, 1.43, 0.835, 91, 91, CRYSTAL STRUCTURE OF 1K1 MUTANT OF HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR FRAGMENT NK1 IN COMPLEX WITH HEPARIN
17, d1bhtA1, 0.9105, 1.43, 0.835, 92, 91, NK1 FRAGMENT OF HUMAN HEPATOCYTE GROWTH FACTOR
18, d2qj2A1, 0.9103, 1.45, 0.835, 91, 91, A MECHANISTIC BASIS FOR CONVERTING A RECEPTOR TYROSINE KINASE AGONIST TO AN ANTAGONIST
19, d3hn4A1, 0.9094, 1.50, 0.835, 93, 91, CRYSTAL STRUCTURE OF THE NK2 FRAGMENT (28-289) OF HUMAN HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR
20, d1gmnA1, 0.9078, 1.32, 0.818, 88, 88, CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR
21, d5cs9B1, 0.9054, 1.34, 0.833, 90, 90, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH MES
22, d5cs1B1, 0.9050, 1.34, 0.833, 90, 90, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF
23, d3sp8B1, 0.9039, 1.33, 0.822, 93, 90, CRYSTAL STRUCTURE OF NK2 IN COMPLEX WITH FRACTIONATED HEPARIN DP10
24, d3mkpC1, 0.9029, 1.55, 0.835, 91, 91, CRYSTAL STRUCTURE OF 1K1 MUTANT OF HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR FRAGMENT NK1 IN COMPLEX WITH HEPARIN
25, d1gmoF1, 0.9024, 1.33, 0.820, 89, 89, CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR
26, d1gmoB1, 0.9022, 1.36, 0.820, 89, 89, CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR
27, d5cp9B1, 0.9019, 1.30, 0.831, 89, 89, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH MB605
28, d5ct1B1, 0.9002, 1.30, 0.831, 89, 89, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH CHES
29, d1gmoC1, 0.9000, 1.31, 0.820, 89, 89, CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR
30, d5ct3B1, 0.8990, 1.31, 0.831, 89, 89, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH 2FA
31, d5csqB1, 0.8989, 1.34, 0.831, 89, 89, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH MOPS
32, d5cs3B1, 0.8986, 1.35, 0.831, 89, 89, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH (H)EPPS
33, d1gmoA1, 0.8986, 1.36, 0.820, 89, 89, CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR
34, d5coeB1, 0.8984, 1.31, 0.831, 89, 89, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH HEPES
35, d3sp8A1, 0.8984, 1.40, 0.822, 92, 90, CRYSTAL STRUCTURE OF NK2 IN COMPLEX WITH FRACTIONATED HEPARIN DP10
36, d5cs5B1, 0.8980, 1.34, 0.831, 89, 89, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH PIPES
37, d4iuaH1, 0.8965, 0.46, 1.000, 83, 83, CRYSTAL STRUCTURE OF THE NK2 FRAGMENT (31-290) OF THE MOUSE HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR
38, d5ct3A1, 0.8964, 1.30, 0.830, 88, 88, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH 2FA
39, d5ct1A1, 0.8961, 1.30, 0.830, 88, 88, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH CHES
40, d5cp9A1, 0.8956, 1.33, 0.830, 88, 88, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH MB605
41, d5cs1A1, 0.8954, 1.31, 0.830, 88, 88, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF
42, d5cs5A1, 0.8951, 1.32, 0.830, 88, 88, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH PIPES
43, d5ct2A1, 0.8944, 1.33, 0.830, 88, 88, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH CAPS
44, d5csqA1, 0.8944, 1.33, 0.830, 88, 88, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH MOPS
45, d5cs3A1, 0.8944, 1.29, 0.830, 88, 88, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH (H)EPPS
46, d1gmoD1, 0.8943, 1.42, 0.820, 89, 89, CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR
47, d5coeA1, 0.8942, 1.32, 0.830, 88, 88, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH HEPES
48, d1gmoE1, 0.8941, 1.39, 0.820, 89, 89, CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR
49, d1gp9C1, 0.8939, 1.33, 0.818, 88, 88, A NEW CRYSTAL FORM OF THE NK1 SPLICE VARIANT OF HGF/SF DEMONSTRATES EXTENSIVE HINGE MOVEMENT AND SUGGESTS THAT THE NK1 DIMER ORIGINATES BY DOMAIN SWAPPING
50, d5cs9A1, 0.8915, 1.35, 0.830, 88, 88, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH MES
51, d1nk1A1, 0.8910, 1.38, 0.830, 88, 88, NK1 FRAGMENT OF HUMAN HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR (HGF/SF) AT 2.5 ANGSTROM RESOLUTION
52, d5ct2B1, 0.8903, 1.36, 0.831, 89, 89, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH CAPS
53, d1nk1B1, 0.8884, 1.40, 0.830, 88, 88, NK1 FRAGMENT OF HUMAN HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR (HGF/SF) AT 2.5 ANGSTROM RESOLUTION
54, d1gmoH1, 0.8882, 1.40, 0.818, 88, 88, CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR
55, d4iuaG1, 0.8858, 0.69, 1.000, 83, 83, CRYSTAL STRUCTURE OF THE NK2 FRAGMENT (31-290) OF THE MOUSE HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR
56, d1gp9A1, 0.8853, 1.36, 0.828, 87, 87, A NEW CRYSTAL FORM OF THE NK1 SPLICE VARIANT OF HGF/SF DEMONSTRATES EXTENSIVE HINGE MOVEMENT AND SUGGESTS THAT THE NK1 DIMER ORIGINATES BY DOMAIN SWAPPING
57, d1gp9D1, 0.8790, 1.39, 0.828, 87, 87, A NEW CRYSTAL FORM OF THE NK1 SPLICE VARIANT OF HGF/SF DEMONSTRATES EXTENSIVE HINGE MOVEMENT AND SUGGESTS THAT THE NK1 DIMER ORIGINATES BY DOMAIN SWAPPING
58, d1gp9B1, 0.8774, 1.36, 0.828, 87, 87, A NEW CRYSTAL FORM OF THE NK1 SPLICE VARIANT OF HGF/SF DEMONSTRATES EXTENSIVE HINGE MOVEMENT AND SUGGESTS THAT THE NK1 DIMER ORIGINATES BY DOMAIN SWAPPING
59, d3mkpD1, 0.8716, 1.45, 0.839, 87, 87, CRYSTAL STRUCTURE OF 1K1 MUTANT OF HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR FRAGMENT NK1 IN COMPLEX WITH HEPARIN
60, d1gmoG1, 0.8461, 0.86, 0.840, 81, 81, CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR
61, d2hgfA_, 0.8195, 1.95, 0.843, 97, 89, HAIRPIN LOOP CONTAINING DOMAIN OF HEPATOCYTE GROWTH FACTOR NMR MINIMIZED AVERAGE STRUCTURE
62, p4durB1, 0.8043, 1.95, 0.843, 97, 89, THE X-RAY CRYSTAL STRUCTURE OF FULL-LENGTH TYPE II HUMAN PLASMINOGEN
63, p4durA1, 0.7923, 1.27, 0.250, 80, 80, THE X-RAY CRYSTAL STRUCTURE OF FULL-LENGTH TYPE II HUMAN PLASMINOGEN
64, p4a5tS1, 0.7908, 1.28, 0.253, 79, 79, STRUCTURAL BASIS FOR THE CONFORMATIONAL MODULATION
65, p4duuA1, 0.7784, 1.55, 0.247, 81, 81, THE X-RAY CRYSTAL STRUCTURE OF FULL-LENGTH TYPE I HUMAN PLASMINOGEN
66, p5h7vA1, 0.7123, 1.55, 0.247, 81, 81, STRUCTURE OF FULL-LENGTH EXTRACELLULAR DOMAIN OF HAI-1 AT PH 4.6
67, p2msxA_, 0.6983, 1.31, 0.253, 79, 79, THE SOLUTION STRUCTURE OF THE MANEC-TYPE DOMAIN FROM HEPATOCYTE GROWTH FACTOR INHIBITOR 1 REVEALS AN UNEXPECTED PAN/APPLE DOMAIN-TYPE FOLD
68, d1i8nC_, 0.6580, 2.43, 0.157, 126, 83, CRYSTAL STRUCTURE OF LEECH ANTI-PLATELET PROTEIN
69, p2yilA1, 0.6555, 2.43, 0.157, 126, 83, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS LECTIN SML-2
70, p2yioB1, 0.6554, 2.86, 0.155, 114, 84, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS MICRONEME PROTEIN SML-2  IN COMPLEX WITH 1-THIO-BETA-D-GALACTOSE ( SPACEGROUP C2221).
71, p2yipB1, 0.6545, 2.78, 0.139, 89, 79, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS MICRONEME PROTEIN SML-2  IN COMPLEX WITH 1-THIO-BETA-D-GALACTOSE ( SPACEGROUP P212121)
72, p2q8aA_, 0.6545, 2.22, 0.147, 78, 75, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
73, p2yipC1, 0.6538, 2.22, 0.147, 78, 75, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS MICRONEME PROTEIN SML-2  IN COMPLEX WITH 1-THIO-BETA-D-GALACTOSE ( SPACEGROUP P212121)
74, p2yilE1, 0.6535, 2.18, 0.147, 78, 75, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS LECTIN SML-2
75, p2yipE1, 0.6533, 2.22, 0.147, 78, 75, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS MICRONEME PROTEIN SML-2  IN COMPLEX WITH 1-THIO-BETA-D-GALACTOSE ( SPACEGROUP P212121)
76, p2yilC1, 0.6533, 2.96, 0.050, 316, 80, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS LECTIN SML-2
77, p2yipF1, 0.6526, 2.96, 0.050, 316, 80, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS MICRONEME PROTEIN SML-2  IN COMPLEX WITH 1-THIO-BETA-D-GALACTOSE ( SPACEGROUP P212121)
78, p2yipA1, 0.6523, 2.18, 0.147, 78, 75, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS MICRONEME PROTEIN SML-2  IN COMPLEX WITH 1-THIO-BETA-D-GALACTOSE ( SPACEGROUP P212121)
79, d1i8nA_, 0.6512, 2.19, 0.147, 78, 75, CRYSTAL STRUCTURE OF LEECH ANTI-PLATELET PROTEIN
80, d1i8nB_, 0.6504, 2.12, 0.149, 78, 74, CRYSTAL STRUCTURE OF LEECH ANTI-PLATELET PROTEIN
81, p1w8kA_, 0.6491, 2.12, 0.149, 78, 74, CRYSTAL STRUCTURE OF APICAL MEMBRANE ANTIGEN 1 FROM PLASMODIUM VIVAX
82, p3zwzA_, 0.6484, 2.12, 0.149, 78, 74, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH A 39AA PFRON2 PEPTIDE
83, p2yilF1, 0.6477, 2.20, 0.147, 78, 75, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS LECTIN SML-2
84, p5nqfA_, 0.6453, 2.83, 0.139, 89, 79, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH A 39 AA PVRON2 PEPTIDE
85, p2yilD1, 0.6445, 2.83, 0.139, 89, 79, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS LECTIN SML-2
86, p2yipD1, 0.6440, 2.84, 0.139, 89, 79, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS MICRONEME PROTEIN SML-2  IN COMPLEX WITH 1-THIO-BETA-D-GALACTOSE ( SPACEGROUP P212121)
87, p2yilB1, 0.6435, 3.02, 0.125, 362, 80, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS LECTIN SML-2
88, p5eokA3, 0.6431, 3.02, 0.125, 362, 80, HUMAN PLASMA COAGULATION FACTOR XI IN COMPLEX WITH PEPTIDE P39
89, p5i25A3, 0.6428, 3.07, 0.075, 297, 80, HUMAN RECOMBINANT COAGULATION FXI IN COMPLEX WITH A PEPTIDE DERIVED FROM HUMAN HIGH MOLECULAR WEIGHT KININOGEN (HKP)
90, p2yioA1, 0.6424, 2.16, 0.151, 77, 73, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS MICRONEME PROTEIN SML-2  IN COMPLEX WITH 1-THIO-BETA-D-GALACTOSE ( SPACEGROUP C2221).
91, p4apmA1, 0.6423, 3.07, 0.087, 298, 80, CRYSTAL STRUCTURE OF AMA1 FROM BABESIA DIVERGENS
92, p2f83A3, 0.6421, 2.18, 0.151, 77, 73, CRYSTAL STRUCTURE AT 2.9 ANGSTROMS RESOLUTION OF HUMAN PLASMA COAGULATION FACTOR XI ZYMOGEN
93, p5eodA2, 0.6408, 2.13, 0.151, 77, 73, HUMAN PLASMA COAGULATION FXI WITH PEPTIDE LP2
94, p4aplD1, 0.6408, 2.13, 0.151, 77, 73, CRYSTAL STRUCTURE OF AMA1 FROM NEOSPORA CANINUM
95, p2y8sA1, 0.6402, 2.85, 0.133, 91, 75, CO-STRUCTURE OF AN AMA1 MUTANT (Y230A) WITH A SURFACE EXPOSED REGION OF RON2 FROM TOXOPLASMA GONDII
96, p4yivA1, 0.6399, 2.86, 0.133, 90, 75, CRYSTAL STRUCTURE OF ENGINEERED TGAMA1 LACKING THE DII LOOP
97, p2y8tA1, 0.6388, 2.23, 0.149, 77, 74, CO-STRUCTURE OF AMA1 WITH A SURFACE EXPOSED REGION OF RON2 FROM TOXOPLASMA GONDII
98, p4aplE1, 0.6383, 2.94, 0.080, 207, 75, CRYSTAL STRUCTURE OF AMA1 FROM NEOSPORA CANINUM
99, p4aplB1, 0.6381, 2.94, 0.080, 207, 75, CRYSTAL STRUCTURE OF AMA1 FROM NEOSPORA CANINUM
100, p4a5vA2, 0.6378, 2.60, 0.135, 91, 74, SOLUTION STRUCTURE ENSEMBLE OF THE TWO N-TERMINAL APPLE DOMAINS (RESIDUES 58-231) OF TOXOPLASMA GONDII MICRONEME PROTEIN 4
101, p2z8vB1, 0.6376, 2.60, 0.135, 91, 74, STRUCTURE OF AN IGNAR-AMA1 COMPLEX
102, p4aplA1, 0.6373, 2.62, 0.135, 89, 74, CRYSTAL STRUCTURE OF AMA1 FROM NEOSPORA CANINUM
103, p2x2zE1, 0.6370, 2.92, 0.103, 184, 78, CRYSTAL STRUCTURE AMA1 FROM TOXOPLASMA GONDII
104, p4yizC2, 0.6366, 2.93, 0.090, 160, 78, CRYSTAL STRUCTURE OF ENGINEERED TGAMA1 LACKING THE DII LOOP IN COMPLEX WITH AN EIMERIA TENELLA RON2D3 PEPTIDE
105, p4yizA1, 0.6366, 2.95, 0.090, 192, 78, CRYSTAL STRUCTURE OF ENGINEERED TGAMA1 LACKING THE DII LOOP IN COMPLEX WITH AN EIMERIA TENELLA RON2D3 PEPTIDE
106, p2x2zA1, 0.6366, 2.94, 0.090, 224, 78, CRYSTAL STRUCTURE AMA1 FROM TOXOPLASMA GONDII
107, p2z8vA1, 0.6364, 2.87, 0.103, 226, 78, STRUCTURE OF AN IGNAR-AMA1 COMPLEX
108, p2z8wB1, 0.6361, 2.88, 0.103, 183, 78, STRUCTURE OF AN IGNAR-AMA1 COMPLEX
109, p2z8wA1, 0.6354, 2.65, 0.093, 83, 75, STRUCTURE OF AN IGNAR-AMA1 COMPLEX
110, p4yizE1, 0.6349, 2.65, 0.093, 83, 75, CRYSTAL STRUCTURE OF ENGINEERED TGAMA1 LACKING THE DII LOOP IN COMPLEX WITH AN EIMERIA TENELLA RON2D3 PEPTIDE
111, p2x2zD1, 0.6347, 2.82, 0.053, 142, 75, CRYSTAL STRUCTURE AMA1 FROM TOXOPLASMA GONDII
112, p2y8sD1, 0.6346, 2.89, 0.103, 218, 78, CO-STRUCTURE OF AN AMA1 MUTANT (Y230A) WITH A SURFACE EXPOSED REGION OF RON2 FROM TOXOPLASMA GONDII
113, p2y8tD1, 0.6341, 2.93, 0.090, 188, 78, CO-STRUCTURE OF AMA1 WITH A SURFACE EXPOSED REGION OF RON2 FROM TOXOPLASMA GONDII
114, p2y8rA1, 0.6340, 2.95, 0.090, 154, 78, CRYSTAL STRUCTURE OF APO AMA1 MUTANT (TYR230ALA) FROM TOXOPLASMA GONDII
115, p2x2zB1, 0.6338, 2.94, 0.090, 181, 78, CRYSTAL STRUCTURE AMA1 FROM TOXOPLASMA GONDII
116, p4r19B1, 0.6330, 2.97, 0.090, 180, 78, CRYSTAL STRUCTURE OF 3D7 STRAIN PLASMODIUM FALCIPARUM AMA1
117, p2y8rE1, 0.6322, 2.81, 0.053, 142, 75, CRYSTAL STRUCTURE OF APO AMA1 MUTANT (TYR230ALA) FROM TOXOPLASMA GONDII
118, p2q8bA1, 0.6319, 2.83, 0.053, 184, 75, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
119, p4r1cB1, 0.6317, 2.82, 0.053, 144, 75, CRYSTAL STRUCTURE OF 3D7 STRAIN PLASMODIUM FALCIPARUM AMA1
120, p4z81A2, 0.6312, 2.96, 0.090, 176, 78, CRYSTAL STRUCTURE OF AMA4 DI-DII-EGF1 FROM TOXOPLASMA GONDII
121, p2y8rB1, 0.6312, 2.97, 0.090, 204, 78, CRYSTAL STRUCTURE OF APO AMA1 MUTANT (TYR230ALA) FROM TOXOPLASMA GONDII
122, p5nqgA1, 0.6311, 2.82, 0.091, 173, 77, CRYSTAL STRUCTURE OF PLASMODIUM VIVAX AMA1 IN COMPLEX WITH A 39 AA PVRON2 PEPTIDE
123, p4r19A1, 0.6310, 2.81, 0.091, 177, 77, CRYSTAL STRUCTURE OF 3D7 STRAIN PLASMODIUM FALCIPARUM AMA1
124, p4z80A2, 0.6305, 2.99, 0.090, 177, 78, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII AMA4 DI-DII-EGF1 IN COMPLEX WITH A 33 AA TGRON2L1 PEPTIDE
125, p1z40E1, 0.6304, 2.96, 0.090, 239, 78, AMA1 FROM PLASMODIUM FALCIPARUM
126, p2y8rD1, 0.6303, 2.96, 0.090, 239, 78, CRYSTAL STRUCTURE OF APO AMA1 MUTANT (TYR230ALA) FROM TOXOPLASMA GONDII
127, p1z40A1, 0.6299, 2.80, 0.080, 139, 75, AMA1 FROM PLASMODIUM FALCIPARUM
128, p4r1bA1, 0.6295, 2.97, 0.090, 174, 78, CRYSTAL STRUCTURE OF 3D7 STRAIN PLASMODIUM FALCIPARUM AMA1
129, p4z80B2, 0.6284, 2.84, 0.053, 150, 75, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII AMA4 DI-DII-EGF1 IN COMPLEX WITH A 33 AA TGRON2L1 PEPTIDE
130, p4r1cA1, 0.6283, 2.85, 0.053, 145, 75, CRYSTAL STRUCTURE OF 3D7 STRAIN PLASMODIUM FALCIPARUM AMA1
131, p1w81A1, 0.6282, 3.21, 0.105, 326, 86, CRYSTAL STRUCTURE OF APICAL MEMBRANE ANTIGEN 1 FROM PLASMODIUM VIVAX
132, p4z81B2, 0.6273, 2.98, 0.090, 178, 78, CRYSTAL STRUCTURE OF AMA4 DI-DII-EGF1 FROM TOXOPLASMA GONDII
133, p4z09A1, 0.6273, 2.84, 0.133, 203, 75, CRYSTAL STRUCTURE OF FVO STRAIN PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH THE RON2HP [THR2040ALA] PEPTIDE
134, p4z0dA1, 0.6272, 2.84, 0.053, 144, 75, CRYSTAL STRUCTURE OF FVO STRAIN PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH THE RON2HP [PHE2038TRP] PEPTIDE
135, p3sriA1, 0.6269, 3.28, 0.105, 327, 86, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH A 29AA PFRON2 PEPTIDE
136, p4r1aA1, 0.6266, 3.28, 0.105, 327, 86, CRYSTAL STRUCTURE OF FVO STRAIN PLASMODIUM FALCIPARUM AMA1
137, p4z0fA1, 0.6263, 2.83, 0.053, 138, 75, CRYSTAL STRUCTURE OF FVO STRAIN PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH THE RON2HP [PHE2038(6CW)] PEPTIDE
138, p4z0eA1, 0.6263, 2.98, 0.090, 180, 78, CRYSTAL STRUCTURE OF FVO STRAIN PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH THE RON2HP [PHE2038TRN] PEPTIDE
139, p3srjB1, 0.6263, 2.83, 0.053, 140, 75, PFAMA1 IN COMPLEX WITH INVASION-INHIBITORY PEPTIDE R1
140, p4uv6A1, 0.6262, 2.85, 0.053, 155, 75, CRYSTAL STRUCTURE OF APICAL MEMBRANE ANTIGEN 1 FROM PLASMODIUM KNOWLESI
141, p5i25A1, 0.6261, 3.35, 0.105, 327, 86, HUMAN RECOMBINANT COAGULATION FXI IN COMPLEX WITH A PEPTIDE DERIVED FROM HUMAN HIGH MOLECULAR WEIGHT KININOGEN (HKP)
142, p5eodA1, 0.6254, 2.85, 0.053, 148, 75, HUMAN PLASMA COAGULATION FXI WITH PEPTIDE LP2
143, p4uv6B1, 0.6253, 2.86, 0.133, 230, 75, CRYSTAL STRUCTURE OF APICAL MEMBRANE ANTIGEN 1 FROM PLASMODIUM KNOWLESI
144, p3srjA1, 0.6252, 3.29, 0.094, 322, 85, PFAMA1 IN COMPLEX WITH INVASION-INHIBITORY PEPTIDE R1
145, p4z81B1, 0.6247, 2.89, 0.093, 144, 75, CRYSTAL STRUCTURE OF AMA4 DI-DII-EGF1 FROM TOXOPLASMA GONDII
146, p5eokA1, 0.6245, 2.89, 0.093, 144, 75, HUMAN PLASMA COAGULATION FACTOR XI IN COMPLEX WITH PEPTIDE P39
147, p4uaoA1, 0.6242, 2.89, 0.093, 147, 75, CRYSTAL STRUCTURE OF APICAL MEMBRANE ANTIGEN 1 FROM PLASMODIUM KNOWLESI IN COMPLEX WITH AN INVASION INHIBITORY ANTIBODY
148, p4z81A3, 0.6240, 2.89, 0.093, 142, 75, CRYSTAL STRUCTURE OF AMA4 DI-DII-EGF1 FROM TOXOPLASMA GONDII
149, p4z80B1, 0.6237, 2.90, 0.093, 147, 75, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII AMA4 DI-DII-EGF1 IN COMPLEX WITH A 33 AA TGRON2L1 PEPTIDE
150, p4z80A1, 0.6232, 2.90, 0.093, 143, 75, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII AMA4 DI-DII-EGF1 IN COMPLEX WITH A 33 AA TGRON2L1 PEPTIDE
151, p5eokA5, 0.6196, 2.90, 0.080, 154, 75, HUMAN PLASMA COAGULATION FACTOR XI IN COMPLEX WITH PEPTIDE P39
152, p5i25A5, 0.6181, 2.87, 0.120, 145, 75, HUMAN RECOMBINANT COAGULATION FXI IN COMPLEX WITH A PEPTIDE DERIVED FROM HUMAN HIGH MOLECULAR WEIGHT KININOGEN (HKP)
153, p5eodA4, 0.6180, 3.00, 0.147, 89, 75, HUMAN PLASMA COAGULATION FXI WITH PEPTIDE LP2
154, p2ll4M_, 0.6171, 2.78, 0.149, 90, 74, HADDOCK STRUCTURE OF TGMIC4-A5/LACTO-N-BIOSE COMPLEX BASED ON NOE- DERIVED DISTANCE RESTRAINTS
155, p5nqgA2, 0.6170, 2.78, 0.149, 90, 74, CRYSTAL STRUCTURE OF PLASMODIUM VIVAX AMA1 IN COMPLEX WITH A 39 AA PVRON2 PEPTIDE
156, p2f83A5, 0.6169, 2.88, 0.120, 145, 75, CRYSTAL STRUCTURE AT 2.9 ANGSTROMS RESOLUTION OF HUMAN PLASMA COAGULATION FACTOR XI ZYMOGEN
157, p5eodA5, 0.6168, 2.91, 0.080, 154, 75, HUMAN PLASMA COAGULATION FXI WITH PEPTIDE LP2
158, p2f83A1, 0.6143, 3.24, 0.077, 136, 78, CRYSTAL STRUCTURE AT 2.9 ANGSTROMS RESOLUTION OF HUMAN PLASMA COAGULATION FACTOR XI ZYMOGEN
159, p5gyyB3, 0.6139, 2.82, 0.149, 88, 74, PLANT RECEPTOR COMPLEX
160, p3zleL3, 0.6133, 2.95, 0.120, 143, 75, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
161, p3zleB1, 0.6128, 3.07, 0.078, 125, 77, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
162, p3zleK2, 0.6126, 3.05, 0.078, 139, 77, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
163, p3zleE2, 0.6120, 3.05, 0.078, 139, 77, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
164, p2ll3A_, 0.6117, 3.05, 0.078, 139, 77, THE SOLUTION STRUCTURE OF TGMIC4 APPLE-5 DOMAIN
165, p3zleH3, 0.6115, 2.83, 0.149, 91, 74, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
166, p5eokA4, 0.6105, 3.01, 0.147, 90, 75, HUMAN PLASMA COAGULATION FACTOR XI IN COMPLEX WITH PEPTIDE P39
167, p3zleH1, 0.6103, 2.82, 0.135, 86, 74, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
168, p5i25A4, 0.6102, 2.21, 0.132, 70, 68, HUMAN RECOMBINANT COAGULATION FXI IN COMPLEX WITH A PEPTIDE DERIVED FROM HUMAN HIGH MOLECULAR WEIGHT KININOGEN (HKP)
169, p3zleF2, 0.6100, 3.15, 0.076, 179, 79, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
170, p3zleE1, 0.6100, 3.01, 0.147, 91, 75, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
171, p3zleL1, 0.6097, 3.01, 0.147, 91, 75, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
172, p3zleA1, 0.6095, 3.25, 0.143, 91, 77, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
173, p3zleB2, 0.6094, 3.25, 0.143, 91, 77, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
174, p3zleJ2, 0.6085, 2.86, 0.149, 88, 74, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
175, p3zleA2, 0.6085, 3.05, 0.160, 141, 75, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
176, p3zleI3, 0.6084, 3.05, 0.160, 141, 75, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
177, p3zleG1, 0.6083, 2.88, 0.104, 166, 77, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
178, p3zleF1, 0.6075, 3.00, 0.105, 213, 76, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
179, p3zldA3, 0.6075, 2.90, 0.104, 166, 77, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1 IN COMPLEX WITH A 36 AA REGION OF SPOROZOITE RON2
180, p3zleD3, 0.6074, 2.90, 0.104, 166, 77, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
181, p3zleD1, 0.6074, 2.23, 0.147, 70, 68, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
182, p3srjB2, 0.6071, 2.23, 0.147, 70, 68, PFAMA1 IN COMPLEX WITH INVASION-INHIBITORY PEPTIDE R1
183, p3zldA1, 0.6070, 2.90, 0.104, 166, 77, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1 IN COMPLEX WITH A 36 AA REGION OF SPOROZOITE RON2
184, p2q8bA2, 0.6068, 3.10, 0.145, 89, 76, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
185, p4apmA2, 0.6064, 3.07, 0.105, 176, 76, CRYSTAL STRUCTURE OF AMA1 FROM BABESIA DIVERGENS
186, p3zleC1, 0.6064, 3.25, 0.143, 91, 77, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
187, p3zleC2, 0.6063, 2.90, 0.104, 166, 77, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
188, p3zleJ1, 0.6059, 3.00, 0.105, 216, 76, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
189, p4r1cA2, 0.6058, 3.00, 0.105, 176, 76, CRYSTAL STRUCTURE OF 3D7 STRAIN PLASMODIUM FALCIPARUM AMA1
190, p3zleG2, 0.6058, 3.21, 0.117, 216, 77, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
191, p3srjA2, 0.6058, 3.21, 0.117, 216, 77, PFAMA1 IN COMPLEX WITH INVASION-INHIBITORY PEPTIDE R1
192, p5gyyA3, 0.6057, 2.72, 0.105, 166, 76, PLANT RECEPTOR COMPLEX
193, p4r1cB2, 0.6057, 2.91, 0.104, 166, 77, CRYSTAL STRUCTURE OF 3D7 STRAIN PLASMODIUM FALCIPARUM AMA1
194, p2y8rD3, 0.6055, 2.72, 0.105, 166, 76, CRYSTAL STRUCTURE OF APO AMA1 MUTANT (TYR230ALA) FROM TOXOPLASMA GONDII
195, p1w81A2, 0.6055, 2.72, 0.105, 166, 76, CRYSTAL STRUCTURE OF APICAL MEMBRANE ANTIGEN 1 FROM PLASMODIUM VIVAX
196, p3zleI1, 0.6054, 2.71, 0.105, 166, 76, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
197, p4r19B2, 0.6051, 3.08, 0.105, 216, 76, CRYSTAL STRUCTURE OF 3D7 STRAIN PLASMODIUM FALCIPARUM AMA1
198, p3zleK1, 0.6047, 3.01, 0.105, 211, 76, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
199, p2z8wA2, 0.6041, 3.14, 0.103, 163, 78, STRUCTURE OF AN IGNAR-AMA1 COMPLEX
200, p4aplE2, 0.6040, 2.72, 0.105, 166, 76, CRYSTAL STRUCTURE OF AMA1 FROM NEOSPORA CANINUM
201, p2f83A2, 0.6039, 3.01, 0.105, 176, 76, CRYSTAL STRUCTURE AT 2.9 ANGSTROMS RESOLUTION OF HUMAN PLASMA COAGULATION FACTOR XI ZYMOGEN
202, p4r19A2, 0.6035, 2.77, 0.066, 143, 76, CRYSTAL STRUCTURE OF 3D7 STRAIN PLASMODIUM FALCIPARUM AMA1
203, p2y8rE3, 0.6032, 3.05, 0.105, 163, 76, CRYSTAL STRUCTURE OF APO AMA1 MUTANT (TYR230ALA) FROM TOXOPLASMA GONDII
204, p4yizE3, 0.6031, 2.80, 0.066, 142, 76, CRYSTAL STRUCTURE OF ENGINEERED TGAMA1 LACKING THE DII LOOP IN COMPLEX WITH AN EIMERIA TENELLA RON2D3 PEPTIDE
205, p4uv6B2, 0.6026, 3.11, 0.089, 132, 79, CRYSTAL STRUCTURE OF APICAL MEMBRANE ANTIGEN 1 FROM PLASMODIUM KNOWLESI
206, p1z40E2, 0.6026, 3.11, 0.089, 132, 79, AMA1 FROM PLASMODIUM FALCIPARUM
207, p4yizA3, 0.6024, 3.04, 0.105, 213, 76, CRYSTAL STRUCTURE OF ENGINEERED TGAMA1 LACKING THE DII LOOP IN COMPLEX WITH AN EIMERIA TENELLA RON2D3 PEPTIDE
208, p2z8vB2, 0.6018, 2.73, 0.105, 166, 76, STRUCTURE OF AN IGNAR-AMA1 COMPLEX
209, p3sriA2, 0.6017, 3.02, 0.105, 213, 76, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH A 29AA PFRON2 PEPTIDE
210, p1z40A2, 0.6010, 3.02, 0.064, 131, 78, AMA1 FROM PLASMODIUM FALCIPARUM
211, p2y8tD3, 0.5999, 2.74, 0.105, 166, 76, CO-STRUCTURE OF AMA1 WITH A SURFACE EXPOSED REGION OF RON2 FROM TOXOPLASMA GONDII
212, p2y8sA3, 0.5999, 2.81, 0.066, 144, 76, CO-STRUCTURE OF AN AMA1 MUTANT (Y230A) WITH A SURFACE EXPOSED REGION OF RON2 FROM TOXOPLASMA GONDII
213, p2z8wB2, 0.5998, 3.16, 0.171, 139, 76, STRUCTURE OF AN IGNAR-AMA1 COMPLEX
214, p4uaoA2, 0.5995, 2.69, 0.067, 117, 75, CRYSTAL STRUCTURE OF APICAL MEMBRANE ANTIGEN 1 FROM PLASMODIUM KNOWLESI IN COMPLEX WITH AN INVASION INHIBITORY ANTIBODY
215, p4z0eA2, 0.5994, 2.98, 0.117, 179, 77, CRYSTAL STRUCTURE OF FVO STRAIN PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH THE RON2HP [PHE2038TRN] PEPTIDE
216, p4z0dA2, 0.5994, 2.96, 0.080, 134, 75, CRYSTAL STRUCTURE OF FVO STRAIN PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH THE RON2HP [PHE2038TRP] PEPTIDE
217, p2z8vA2, 0.5993, 3.03, 0.105, 171, 76, STRUCTURE OF AN IGNAR-AMA1 COMPLEX
218, p4z09A2, 0.5989, 3.35, 0.062, 178, 80, CRYSTAL STRUCTURE OF FVO STRAIN PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH THE RON2HP [THR2040ALA] PEPTIDE
219, p4aplA2, 0.5983, 3.03, 0.105, 214, 76, CRYSTAL STRUCTURE OF AMA1 FROM NEOSPORA CANINUM
220, p4a5vA1, 0.5979, 3.12, 0.065, 178, 77, SOLUTION STRUCTURE ENSEMBLE OF THE TWO N-TERMINAL APPLE DOMAINS (RESIDUES 58-231) OF TOXOPLASMA GONDII MICRONEME PROTEIN 4
221, p2y8rB3, 0.5978, 3.07, 0.130, 164, 77, CRYSTAL STRUCTURE OF APO AMA1 MUTANT (TYR230ALA) FROM TOXOPLASMA GONDII
222, p2y8tA2, 0.5969, 2.97, 0.147, 89, 75, CO-STRUCTURE OF AMA1 WITH A SURFACE EXPOSED REGION OF RON2 FROM TOXOPLASMA GONDII
223, p2y8rA3, 0.5969, 3.41, 0.062, 177, 80, CRYSTAL STRUCTURE OF APO AMA1 MUTANT (TYR230ALA) FROM TOXOPLASMA GONDII
224, p4aplD3, 0.5962, 2.81, 0.118, 177, 76, CRYSTAL STRUCTURE OF AMA1 FROM NEOSPORA CANINUM
225, p4z0fA2, 0.5958, 3.15, 0.117, 164, 77, CRYSTAL STRUCTURE OF FVO STRAIN PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH THE RON2HP [PHE2038(6CW)] PEPTIDE
226, p4r1aA2, 0.5934, 2.98, 0.092, 180, 76, CRYSTAL STRUCTURE OF FVO STRAIN PLASMODIUM FALCIPARUM AMA1
227, p4r1bA2, 0.5911, 3.07, 0.064, 132, 78, CRYSTAL STRUCTURE OF 3D7 STRAIN PLASMODIUM FALCIPARUM AMA1
228, p2j8jA_, 0.5890, 3.16, 0.117, 164, 77, SOLUTION STRUCTURE OF THE A4 DOMAIN OF BLOOD COAGULATION FACTOR XI
229, p2j8lA_, 0.5835, 2.95, 0.066, 151, 76, FXI APPLE 4 DOMAIN LOOP-OUT CONFORMATION
230, p2j8lB_, 0.5760, 3.00, 0.091, 139, 77, FXI APPLE 4 DOMAIN LOOP-OUT CONFORMATION
231, p2k13X_, 0.5691, 3.06, 0.064, 136, 78, SOLUTION NMR STRUCTURE OF THE LEECH PROTEIN SARATIN A NOVEL INHIBITOR OF HAEMOSTASIS
232, p2j8jB_, 0.5680, 3.12, 0.117, 177, 77, SOLUTION STRUCTURE OF THE A4 DOMAIN OF BLOOD COAGULATION FACTOR XI
233, p4opeA1, 0.5622, 3.13, 0.117, 179, 77, STREPTOMCYES ALBUS JA3453 OXAZOLOMYCIN KETOSYNTHASE DOMAIN OZMH KS7
234, d1hkyA1, 0.5616, 3.15, 0.064, 151, 78, SOLUTION STRUCTURE OF A PAN MODULE FROM EIMERIA TENELLA
235, d1tqyA2, 0.5615, 3.06, 0.092, 189, 76, THE ACTINORHODIN KETOSYNTHASE/CHAIN LENGTH FACTOR
236, d4jgaA2, 0.5567, 3.20, 0.077, 127, 78, X-RAY CRYSTAL STRUCTURE OF 3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 2 FROM RICKETTSIA RICKETTSII
237, d3e60A2, 0.5531, 3.02, 0.079, 129, 76, CRYSTAL STRUCTURE OF 3-OXOACYL-(ACYL CARRIER PROTEIN) SYNTHASE II FROM BARTONELLA HENSELAE
238, p2pffD5, 0.5488, 3.31, 0.063, 180, 79, STRUCTURAL INSIGHTS OF YEAST FATTY ACID SYNTHASE
239, d1tqyG2, 0.5481, 3.19, 0.077, 126, 78, THE ACTINORHODIN KETOSYNTHASE/CHAIN LENGTH FACTOR
240, d3o04A2, 0.5427, 3.03, 0.130, 180, 77, CRYSTAL STRUCTURE OF THE BETA-KETO-ACYL CARRIER PROTEIN SYNTHASE II (LMO2201) FROM LISTERIA MONOCYTOGENES
241, d4jv3A2, 0.5386, 3.03, 0.130, 180, 77, CRYSTAL STRUCTURE OF BETA-KETOACYL SYNTHASE FROM BRUCELLA MELITENSIS IN COMPLEX WITH PLATENCIN
242, d2gqdB2, 0.5377, 2.04, 0.147, 78, 68, THE CRYSTAL STRUCTURE OF B-KETOACYL-ACP SYNTHASE II (FABF) FROM STAPHYLOCOCCUS AUREUS
243, d4ddoA2, 0.5372, 2.04, 0.147, 78, 68, CRYSTAL STRUCTURE OF 3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE II FROM BURKHOLDERIA VIETNAMIENSIS
244, d3mqdA2, 0.5366, 2.98, 0.117, 174, 77, CRYSTAL STRUCTURE OF BETA-KETOACYL SYNTHASE FROM BRUCELLA MELITENSIS WITH FOL 0758 (1-METHYL-1H-INDAZOL-3-YL) METHANOL
245, p2vz9A1, 0.5364, 3.11, 0.117, 164, 77, CRYSTAL STRUCTURE OF MAMMALIAN FATTY ACID SYNTHASE IN COMPLEX WITH NADP
246, p6et9C_, 0.5363, 3.20, 0.130, 175, 77, STRUCTURE OF THE ACETOACETYL-COA-THIOLASE/HMG-COA-SYNTHASE COMPLEX FROM METHANOTHERMOCOCCUS THERMOLITHOTROPHICUS AT 2.75 A
247, d3u0fA2, 0.5357, 3.04, 0.130, 164, 77, THE STRUCTURE OF BETA-KETOACYL SYNTHASE FROM BRUCELLA MELITENSIS BOUND TO THE FRAGMENT 7-HYDROXYCOUMARIN
248, d4jrmA2, 0.5343, 3.03, 0.078, 131, 77, CRYSTAL STRUCTURE OF BETA-KETOACYL-ACP SYNTHASE II (FABF) FROM VIBRIO CHOLERAE (SPACE GROUP P212121) AT 1.75 ANGSTROM
249, d2hg4F3, 0.5342, 2.87, 0.080, 123, 75, STRUCTURE OF THE KETOSYNTHASE-ACYLTRANSFERASE DIDOMAIN OF MODULE 5 FROM DEBS.
250, d4jrmB2, 0.5337, 3.32, 0.064, 127, 78, CRYSTAL STRUCTURE OF BETA-KETOACYL-ACP SYNTHASE II (FABF) FROM VIBRIO CHOLERAE (SPACE GROUP P212121) AT 1.75 ANGSTROM
251, d2hg4A3, 0.5325, 2.94, 0.133, 90, 75, STRUCTURE OF THE KETOSYNTHASE-ACYLTRANSFERASE DIDOMAIN OF MODULE 5 FROM DEBS.
252, p4yzoC_, 0.5314, 3.10, 0.145, 90, 76, CRYSTAL STRUCTURE ANALYSIS OF THIOLASE-LIKE PROTEIN ST0096 FROM SULFOLOBUS TOKODAII
253, d2hg4D3, 0.5312, 3.16, 0.145, 90, 76, STRUCTURE OF THE KETOSYNTHASE-ACYLTRANSFERASE DIDOMAIN OF MODULE 5 FROM DEBS.
254, p4yzoD_, 0.5308, 3.25, 0.154, 103, 78, CRYSTAL STRUCTURE ANALYSIS OF THIOLASE-LIKE PROTEIN ST0096 FROM SULFOLOBUS TOKODAII
255, d2hg4B3, 0.5304, 3.25, 0.154, 103, 78, STRUCTURE OF THE KETOSYNTHASE-ACYLTRANSFERASE DIDOMAIN OF MODULE 5 FROM DEBS.
256, d2hg4E3, 0.5297, 3.31, 0.143, 90, 77, STRUCTURE OF THE KETOSYNTHASE-ACYLTRANSFERASE DIDOMAIN OF MODULE 5 FROM DEBS.
257, d4ls7A2, 0.5289, 3.11, 0.071, 443, 70, CRYSTAL STRUCTURE OF BACILLUS SUBTILIS BETA-KETOACYL-ACP SYNTHASE II (FABF) IN A NON-COVALENT COMPLEX WITH CERULENIN
258, d4jrmC2, 0.5288, 3.11, 0.071, 443, 70, CRYSTAL STRUCTURE OF BETA-KETOACYL-ACP SYNTHASE II (FABF) FROM VIBRIO CHOLERAE (SPACE GROUP P212121) AT 1.75 ANGSTROM
259, p5fwsA2, 0.5287, 2.88, 0.123, 78, 73, WNT MODULATOR KREMEN CRYSTAL FORM I AT 1.90A
260, d4ls5A2, 0.5286, 2.88, 0.123, 78, 73, CRYSTAL STRUCTURE OF BETA-KETOACYL-ACP SYNTHASE II (FABF) FROM BACILLUS SUBTILIS
261, d4qavB2, 0.5283, 2.58, 0.030, 166, 67, THE STRUCTURE OF BETA-KETOACYL -(ACYL CARRIER PROTEIN) SYNTHASE II (FABF) FROM NEISSERIA MENINGITIDIS
262, p5fwuA3, 0.5281, 2.58, 0.030, 166, 67, WNT MODULATOR KREMEN CRYSTAL FORM II AT 2.8A
263, p5fwtA2, 0.5278, 2.58, 0.031, 162, 65, WNT MODULATOR KREMEN CRYSTAL FORM I AT 2.10A
264, d4ls6A2, 0.5278, 2.51, 0.046, 161, 65, CRYSTAL STRUCTURE OF BETA-KETOACYL-ACP SYNTHASE II (FABF) I108F MUTANT FROM BACILLUS SUBTILIS
265, d4qavA2, 0.5274, 2.91, 0.056, 611, 71, THE STRUCTURE OF BETA-KETOACYL -(ACYL CARRIER PROTEIN) SYNTHASE II (FABF) FROM NEISSERIA MENINGITIDIS
266, p5fwvA2, 0.5265, 2.91, 0.056, 611, 71, WNT MODULATOR KREMEN CRYSTAL FORM III AT 3.2A
267, d4r8eB2, 0.5257, 2.67, 0.029, 166, 68, CRYSTAL STRUCTURE OF BETA-KETOACYL-ACP SYNTHASE II (FABF) FROM YERSINIA PESTIS
268, p5my2B1, 0.5252, 2.67, 0.045, 159, 66, KS-MAT DI-DOMAIN OF MOUSE FAS
269, d4f32A2, 0.5250, 3.04, 0.030, 158, 66, CRYSTAL STRUCTURE OF 3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE II FROM BURKHOLDERIA VIETNAMIENSIS IN COMPLEX WITH PLATENCIN
270, p5fwwB3, 0.5237, 2.55, 0.062, 162, 65, WNT MODULATOR KREMEN IN COMPLEX WITH DKK1 (CRD2) AND LRP6 (PE3PE4)
271, d2buhB2, 0.5191, 2.58, 0.031, 162, 65, E. COLI BETA-KETOACYL (ACYL CARRIER PROTEIN) SYNTHASE I 120 K
272, d1og8B4, 0.5191, 3.00, 0.030, 158, 66,  
273, p3vs9C_, 0.5188, 3.20, 0.000, 445, 70, CRYSTAL STRUCTURE OF TYPE III PKS ARSC MUTANT
274, p3vs8D_, 0.5181, 2.97, 0.070, 389, 71, CRYSTAL STRUCTURE OF TYPE III PKS ARSC
275, d2bywA2, 0.5173, 3.01, 0.030, 158, 66, STRUCTURE OF ESCHERICHIA COLI BETA-KETOACYL (ACYL CARRIER PROTEIN) SYNTHASE I LYS328ALA MUTANT
276, d1oeqA4, 0.5173, 2.77, 0.015, 162, 65,  
277, d2byyD2, 0.5166, 2.98, 0.045, 180, 67, E. COLI KAS I H298E MUTATION
278, d2bywC2, 0.5148, 2.76, 0.015, 162, 65, STRUCTURE OF ESCHERICHIA COLI BETA-KETOACYL (ACYL CARRIER PROTEIN) SYNTHASE I LYS328ALA MUTANT
279, d1oeqC4, 0.5148, 2.99, 0.045, 177, 67,  
280, d1h4fB2, 0.5138, 2.97, 0.070, 341, 71, E. COLI BETA-KETOACYL [ACYL CARRIER PROTEIN] SYNTHASE I K328R
281, p5ab6D_, 0.5132, 3.00, 0.045, 179, 67, CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI SCP2-THIOLASE LIKE PROTEIN (TBSLP) IN COMPLEX WITH ACETOACETYL-COA.
282, d1oxhD2, 0.5127, 2.97, 0.070, 341, 71, THE CRYSTAL STRUCTURE OF BETA-KETOACYL-[ACYL CARRIER PROTEIN] SYNTHASE II FROM STREPTOCOCCUS PNEUMONIAE TRICLINIC FORM
283, d4ewgA2, 0.5126, 3.01, 0.045, 177, 67, CRYSTAL STRUCTURE OF A BETA-KETOACYL SYNTHASE FROM BURKHOLDERIA PHYMATUM STM815
284, d5sxoA2, 0.5122, 3.00, 0.045, 179, 67, 1.35 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF BETA-KETOACYL-ACP SYNTHASE II (FABF) FROM LISTERIA MONOCYTOGENES
285, d4ewgB2, 0.5118, 2.89, 0.030, 162, 67, CRYSTAL STRUCTURE OF A BETA-KETOACYL SYNTHASE FROM BURKHOLDERIA PHYMATUM STM815
286, d1oxhB2, 0.5113, 2.79, 0.031, 162, 65, THE CRYSTAL STRUCTURE OF BETA-KETOACYL-[ACYL CARRIER PROTEIN] SYNTHASE II FROM STREPTOCOCCUS PNEUMONIAE TRICLINIC FORM
287, d1tqyF2, 0.5109, 3.38, 0.145, 94, 69, THE ACTINORHODIN KETOSYNTHASE/CHAIN LENGTH FACTOR
288, d1oxhC2, 0.5108, 3.38, 0.145, 94, 69, THE CRYSTAL STRUCTURE OF BETA-KETOACYL-[ACYL CARRIER PROTEIN] SYNTHASE II FROM STREPTOCOCCUS PNEUMONIAE TRICLINIC FORM
289, d2almA2, 0.5096, 2.87, 0.030, 162, 67, CRYSTAL STRUCTURE ANALYSIS OF A MUTANT BETA-KETOACYL-[ACYL CARRIER PROTEIN] SYNTHASE II FROM STREPTOCOCCUS PNEUMONIAE
290, p5ab5B_, 0.5095, 2.74, 0.031, 161, 65, CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI SCP2-THIOLASE LIKE PROTEIN (TBSLP) FORM-II.
291, d2rjtB2, 0.5093, 3.30, 0.116, 94, 69, CRYSTAL STRUCTURE ANALYSIS OF A SURFACE ENTROPY REDUCTION MUTANT OF S. PNEUMONIAE FABF
292, d1ox0A2, 0.5085, 3.41, 0.145, 94, 69, THE CRYSTAL STRUCTURE OF BETA-KETOACYL-[ACYL CARRIER PROTEIN] SYNTHASE II FROM STREPTOCOCCUS PNEUMONIAE
293, d2vb8D2, 0.5080, 2.88, 0.030, 162, 67, BETA-KETOACYL-ACP SYNTHASE I (KAS) FROM E. COLI WITH BOUND INHIBITOR THIOLACTOMYCIN
294, d2rjtD2, 0.5061, 2.54, 0.031, 161, 64, CRYSTAL STRUCTURE ANALYSIS OF A SURFACE ENTROPY REDUCTION MUTANT OF S. PNEUMONIAE FABF
295, d1tqyD2, 0.5061, 3.40, 0.145, 94, 69, THE ACTINORHODIN KETOSYNTHASE/CHAIN LENGTH FACTOR
296, d2vbaB2, 0.5051, 2.74, 0.031, 161, 65, BETA-KETOACYL-ACP SYNTHASE I (KAS) FROM E. COLI WITH BOUND AMINO-THIAZOLE INHIBITOR
297, d1tqyB2, 0.5047, 2.90, 0.015, 420, 66, THE ACTINORHODIN KETOSYNTHASE/CHAIN LENGTH FACTOR
298, d1tqyH2, 0.5043, 2.94, 0.030, 161, 66, THE ACTINORHODIN KETOSYNTHASE/CHAIN LENGTH FACTOR
299, d2bz4D2, 0.5014, 3.05, 0.138, 92, 65, STRUCTURE OF E. COLI KAS I H298Q MUTANT
300, d2oo3A1, 0.5006, 2.95, 0.016, 153, 63, CRYSTAL STRUCTURE OF PROTEIN LPL1258 FROM LEGIONELLA PNEUMOPHILA STR. PHILADELPHIA 1 PFAM DUF519
